110 related articles for article (PubMed ID: 7680485)
1. Possible involvement of the spinal substance P system in pilocarpine-induced scratching in mice.
Sakurada T; Manome Y; Tan-No K; Matsunaga Y; Sakurada S; Kisara K
Pharmacol Biochem Behav; 1993 Feb; 44(2):439-45. PubMed ID: 7680485
[TBL] [Abstract][Full Text] [Related]
2. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.
Sakurada T; Wako K; Sakurada C; Manome Y; Tan-no K; Sakurada S; Kisara K
Brain Res; 1996 Jun; 724(2):213-21. PubMed ID: 8828571
[TBL] [Abstract][Full Text] [Related]
3. Pilocarpine-induced reciprocal hindlimb scratching in mice.
Scott RW; Goode TL; Raffa RB
Pharmacol Biochem Behav; 1987 Feb; 26(2):327-31. PubMed ID: 2437594
[TBL] [Abstract][Full Text] [Related]
4. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
[TBL] [Abstract][Full Text] [Related]
5. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
[TBL] [Abstract][Full Text] [Related]
6. Interactions of substance P antagonists with serotonin in the mouse spinal cord.
Vaught JL; Scott R
Peptides; 1988; 9(4):909-13. PubMed ID: 2465543
[TBL] [Abstract][Full Text] [Related]
7. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
[TBL] [Abstract][Full Text] [Related]
8. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord.
Sakurada T; Yamada T; Tan-no K; Manome Y; Sakurada S; Kisara K; Ohba M
J Pharmacol Exp Ther; 1991 Oct; 259(1):205-10. PubMed ID: 1717679
[TBL] [Abstract][Full Text] [Related]
10. Sensory and motor functions of spinal cord substance P.
Piercey MF; Schroeder LA; Folkers K; Xu JC; Horig J
Science; 1981 Dec; 214(4527):1361-3. PubMed ID: 6171882
[TBL] [Abstract][Full Text] [Related]
11. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone.
Freedman J; Hökfelt T; Post C; Brodin E; Sundström E; Jonsson G; Terenius L; Leander S; Fischer JA; Verhofstad A
Exp Brain Res; 1989; 74(2):279-92. PubMed ID: 2466686
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
[TBL] [Abstract][Full Text] [Related]
14. Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cord.
Larson AA; Sun X
J Neurosci; 1992 Dec; 12(12):4905-10. PubMed ID: 1281498
[TBL] [Abstract][Full Text] [Related]
15. Vasoconstrictor effects in spinal cord of the substance P antagonist [D-Arg, D-Trp7,9 Leu11]-substance P (Spantide) and somatostatin and interaction with thyrotropin releasing hormone.
Freedman J; Post C; Kåhrström J; Ohlen A; Mollenholt P; Owman C; Alari L; Hökfelt T
Neuroscience; 1988 Oct; 27(1):267-78. PubMed ID: 2462190
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
Keeler JR; Charlton CG; Helke CJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
[TBL] [Abstract][Full Text] [Related]
17. Effects of the substance P antagonist [D-Arg1,D-Pro2,D-Trp7,9,Leu11]SP on miosis caused by echothiophate iodide or pilocarpine hydrochloride.
Mandahl A
Eur J Pharmacol; 1985 Aug; 114(2):121-7. PubMed ID: 2412852
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice.
Sakurada T; Katsumata K; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M
Eur J Pharmacol; 1993 Sep; 242(1):47-52. PubMed ID: 7693495
[TBL] [Abstract][Full Text] [Related]
19. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord.
Sakurada T; Katsumata K; Tan-No K; Sakurada S; Kisara K
Neuropharmacology; 1992 Dec; 31(12):1279-85. PubMed ID: 1281912
[TBL] [Abstract][Full Text] [Related]
20. D-Arg1, D-Trp7,9, Leu11-substance P (spantide) does not antagonize substance P-induced hyperexcitability of the nociceptive flexion withdrawal reflex in the rat.
Wiesenfeld-Hallin Z; Duranti R
Acta Physiol Scand; 1987 Jan; 129(1):55-9. PubMed ID: 2436439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
